High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population

• Camille C.B. Kockerols,
• Inge G.P. Geelen,
• Mark-David Levin,
• Jeroen J.W.M. Janssen,
• H. Berna Beveloo,
• Avinash G. Dinmohamed,
• Mels Hoogendoorn,
• Jan J. Cornelissen,
• Peter E. Westerweel

Affiliations

Camille C.B. Kockerols

dept. of Internal Medicine, Albert Schweitzer Hospital, Dordrecht

Inge G.P. Geelen

dept. of Hematology, Erasmus Medical Center, Rotterdam

Mark-David Levin

dept. of Internal Medicine, Albert Schweitzer Hospital, Dordrecht

Jeroen J.W.M. Janssen

dept. of Hematology, Radboud University Medical Center, Nijmegen

H. Berna Beveloo

dept. of Clinical Genetics, Erasmus Medical Center, Rotterdam

Avinash G. Dinmohamed

dept. of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht; dept. of Public Health, Erasmus University Medical Center, Rotterdam; dept. of Hematology, Amsterdam University Medical Center, location VUMC, Amsterdam

Mels Hoogendoorn

dept. of Hematology, Medical Center Leeuwarden, Leeuwarden

Jan J. Cornelissen

dept. of Hematology, Erasmus Medical Center, Rotterdam

Peter E. Westerweel

dept. of Internal Medicine, Albert Schweitzer Hospital, Dordrecht